Global Anti-obesity Drugs Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 21/11/2022
- NO OF PAGES
- 256
- CATEGORY
- Healthcare & Life Sciences
The Anti-obesity Drugs market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Anti-obesity Drugs market. On the basis of historic growth analysis and current scenario of Anti-obesity Drugs market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tool that facilitate deeper understanding of multiple aspects of global Anti-obesity Drugs market. These further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Anti-obesity Drugs market, including demand-supply scenario, pricing structure, profit margins, production and value chain / ecosystem analysis. Regional assessment of global Anti-obesity Drugs market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Market Segmentations:
Global Anti-obesity Drugs Market: Top Key Players
Merck
Vivus
Arena Pharmaceuticals
Novo Nordisk
Orexigen Therapeutics
Pfizer
Alizyme
GlaxoSmithKline
Roche
Amylin
Boehringer Ingelheim
Eisai
Global Anti-obesity Drugs Market: By Types
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs Market: By Applications
Kids
Adults
Global Anti-obesity Drugs Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Anti-obesity Drugs market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as of South America.
Global Anti-obesity Drugs Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Key Reasons to Purchase
• To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the market.
• Besides the standard structure reports, we also provide custom research according to specific requirements.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023This report examines all the key factors influencing growth of global Anti-obesity Drugs market, including demand-supply scenario, pricing structure, profit margins, production and value chain / ecosystem analysis. Regional assessment of global Anti-obesity Drugs market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Market Segmentations:
Global Anti-obesity Drugs Market: Top Key Players
Merck
Vivus
Arena Pharmaceuticals
Novo Nordisk
Orexigen Therapeutics
Pfizer
Alizyme
GlaxoSmithKline
Roche
Amylin
Boehringer Ingelheim
Eisai
Global Anti-obesity Drugs Market: By Types
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs Market: By Applications
Kids
Adults
Global Anti-obesity Drugs Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Anti-obesity Drugs market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as of South America.
Global Anti-obesity Drugs Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Key Reasons to Purchase
• To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the market.
• Besides the standard structure reports, we also provide custom research according to specific requirements.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-obesity Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-obesity Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Peripherally Acting Anti-obesity Drugs
1.4.3 Centrally Acting Anti-obesity Drugs
1.5 Market by Application
1.5.1 Global Anti-obesity Drugs Market Share by Application: 2021-2026
1.5.2 Kids
1.5.3 Adults
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Drugs Market Perspective (2021-2026)
2.2 Anti-obesity Drugs Growth Trends by Regions
2.2.1 Anti-obesity Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Anti-obesity Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Anti-obesity Drugs Forecasted Market Size by Regions (2021-2026)
3 Market Competition by Manufacturers
3.1 Global Anti-obesity Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Anti-obesity Drugs Average Price by Manufacturers (2015-2020)
4 Anti-obesity Drugs Production by Regions
4.1 North America
4.1.1 North America Anti-obesity Drugs Market Size (2015-2026)
4.1.2 Anti-obesity Drugs Key Players in North America (2015-2020)
4.1.3 North America Anti-obesity Drugs Market Size by Type (2015-2020)
4.1.4 North America Anti-obesity Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Anti-obesity Drugs Market Size (2015-2026)
4.2.2 Anti-obesity Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Anti-obesity Drugs Market Size (2015-2026)
4.3.2 Anti-obesity Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Anti-obesity Drugs Market Size by Type (2015-2020)
4.3.4 Europe Anti-obesity Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Anti-obesity Drugs Market Size (2015-2026)
4.4.2 Anti-obesity Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Anti-obesity Drugs Market Size (2015-2026)
4.5.2 Anti-obesity Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Anti-obesity Drugs Market Size (2015-2026)
4.6.2 Anti-obesity Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Anti-obesity Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Anti-obesity Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Anti-obesity Drugs Market Size (2015-2026)
4.7.2 Anti-obesity Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Anti-obesity Drugs Market Size by Type (2015-2020)
4.7.4 Africa Anti-obesity Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Anti-obesity Drugs Market Size (2015-2026)
4.8.2 Anti-obesity Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Anti-obesity Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Anti-obesity Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Anti-obesity Drugs Market Size (2015-2026)
4.9.2 Anti-obesity Drugs Key Players in South America (2015-2020)
4.9.3 South America Anti-obesity Drugs Market Size by Type (2015-2020)
4.9.4 South America Anti-obesity Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Anti-obesity Drugs Market Size (2015-2026)
4.10.2 Anti-obesity Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Anti-obesity Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Anti-obesity Drugs Market Size by Application (2015-2020)
5 Anti-obesity Drugs Consumption by Region
5.1 North America
5.1.1 North America Anti-obesity Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Anti-obesity Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Anti-obesity Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Anti-obesity Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Anti-obesity Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Anti-obesity Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Anti-obesity Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Anti-obesity Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Anti-obesity Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Anti-obesity Drugs Consumption by Countries
5.10.2 Kazakhstan
6 Anti-obesity Drugs Sales Market by Type (2015-2026)
6.1 Global Anti-obesity Drugs Historic Market Size by Type (2015-2020)
6.2 Global Anti-obesity Drugs Forecasted Market Size by Type (2021-2026)
7 Anti-obesity Drugs Consumption Market by Application(2015-2026)
7.1 Global Anti-obesity Drugs Historic Market Size by Application (2015-2020)
7.2 Global Anti-obesity Drugs Forecasted Market Size by Application (2021-2026)
8 Company Profiles and Key Figures in Anti-obesity Drugs Business
8.1 Merck
8.1.1 Merck Company Profile
8.1.2 Merck Anti-obesity Drugs Product Specification
8.1.3 Merck Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Vivus
8.2.1 Vivus Company Profile
8.2.2 Vivus Anti-obesity Drugs Product Specification
8.2.3 Vivus Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Arena Pharmaceuticals
8.3.1 Arena Pharmaceuticals Company Profile
8.3.2 Arena Pharmaceuticals Anti-obesity Drugs Product Specification
8.3.3 Arena Pharmaceuticals Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Novo Nordisk
8.4.1 Novo Nordisk Company Profile
8.4.2 Novo Nordisk Anti-obesity Drugs Product Specification
8.4.3 Novo Nordisk Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Orexigen Therapeutics
8.5.1 Orexigen Therapeutics Company Profile
8.5.2 Orexigen Therapeutics Anti-obesity Drugs Product Specification
8.5.3 Orexigen Therapeutics Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Pfizer
8.6.1 Pfizer Company Profile
8.6.2 Pfizer Anti-obesity Drugs Product Specification
8.6.3 Pfizer Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Alizyme
8.7.1 Alizyme Company Profile
8.7.2 Alizyme Anti-obesity Drugs Product Specification
8.7.3 Alizyme Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Company Profile
8.8.2 GlaxoSmithKline Anti-obesity Drugs Product Specification
8.8.3 GlaxoSmithKline Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Roche
8.9.1 Roche Company Profile
8.9.2 Roche Anti-obesity Drugs Product Specification
8.9.3 Roche Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Amylin
8.10.1 Amylin Company Profile
8.10.2 Amylin Anti-obesity Drugs Product Specification
8.10.3 Amylin Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Boehringer Ingelheim
8.11.1 Boehringer Ingelheim Company Profile
8.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Specification
8.11.3 Boehringer Ingelheim Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Eisai
8.12.1 Eisai Company Profile
8.12.2 Eisai Anti-obesity Drugs Product Specification
8.12.3 Eisai Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Anti-obesity Drugs (2021-2026)
9.2 Global Forecasted Revenue of Anti-obesity Drugs (2021-2026)
9.3 Global Forecasted Price of Anti-obesity Drugs (2015-2026)
9.4 Global Forecasted Production of Anti-obesity Drugs by Region (2021-2026)
9.4.1 North America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Anti-obesity Drugs by Application (2021-2026)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Anti-obesity Drugs by Country
10.2 East Asia Market Forecasted Consumption of Anti-obesity Drugs by Country
10.3 Europe Market Forecasted Consumption of Anti-obesity Drugs by Countriy
10.4 South Asia Forecasted Consumption of Anti-obesity Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Anti-obesity Drugs by Country
10.6 Middle East Forecasted Consumption of Anti-obesity Drugs by Country
10.7 Africa Forecasted Consumption of Anti-obesity Drugs by Country
10.8 Oceania Forecasted Consumption of Anti-obesity Drugs by Country
10.9 South America Forecasted Consumption of Anti-obesity Drugs by Country
10.10 Rest of the world Forecasted Consumption of Anti-obesity Drugs by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.2 Anti-obesity Drugs Distributors List
11.3 Anti-obesity Drugs Customers
12 Industry Trends and Growth Strategy
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Anti-obesity Drugs Market Growth Strategy
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-obesity Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-obesity Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Peripherally Acting Anti-obesity Drugs
1.4.3 Centrally Acting Anti-obesity Drugs
1.5 Market by Application
1.5.1 Global Anti-obesity Drugs Market Share by Application: 2021-2026
1.5.2 Kids
1.5.3 Adults
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Drugs Market Perspective (2021-2026)
2.2 Anti-obesity Drugs Growth Trends by Regions
2.2.1 Anti-obesity Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Anti-obesity Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Anti-obesity Drugs Forecasted Market Size by Regions (2021-2026)
3 Market Competition by Manufacturers
3.1 Global Anti-obesity Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Anti-obesity Drugs Average Price by Manufacturers (2015-2020)
4 Anti-obesity Drugs Production by Regions
4.1 North America
4.1.1 North America Anti-obesity Drugs Market Size (2015-2026)
4.1.2 Anti-obesity Drugs Key Players in North America (2015-2020)
4.1.3 North America Anti-obesity Drugs Market Size by Type (2015-2020)
4.1.4 North America Anti-obesity Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Anti-obesity Drugs Market Size (2015-2026)
4.2.2 Anti-obesity Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Anti-obesity Drugs Market Size (2015-2026)
4.3.2 Anti-obesity Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Anti-obesity Drugs Market Size by Type (2015-2020)
4.3.4 Europe Anti-obesity Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Anti-obesity Drugs Market Size (2015-2026)
4.4.2 Anti-obesity Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Anti-obesity Drugs Market Size (2015-2026)
4.5.2 Anti-obesity Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Anti-obesity Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Anti-obesity Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Anti-obesity Drugs Market Size (2015-2026)
4.6.2 Anti-obesity Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Anti-obesity Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Anti-obesity Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Anti-obesity Drugs Market Size (2015-2026)
4.7.2 Anti-obesity Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Anti-obesity Drugs Market Size by Type (2015-2020)
4.7.4 Africa Anti-obesity Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Anti-obesity Drugs Market Size (2015-2026)
4.8.2 Anti-obesity Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Anti-obesity Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Anti-obesity Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Anti-obesity Drugs Market Size (2015-2026)
4.9.2 Anti-obesity Drugs Key Players in South America (2015-2020)
4.9.3 South America Anti-obesity Drugs Market Size by Type (2015-2020)
4.9.4 South America Anti-obesity Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Anti-obesity Drugs Market Size (2015-2026)
4.10.2 Anti-obesity Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Anti-obesity Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Anti-obesity Drugs Market Size by Application (2015-2020)
5 Anti-obesity Drugs Consumption by Region
5.1 North America
5.1.1 North America Anti-obesity Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Anti-obesity Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Anti-obesity Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Anti-obesity Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Anti-obesity Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Anti-obesity Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Anti-obesity Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Anti-obesity Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Anti-obesity Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Anti-obesity Drugs Consumption by Countries
5.10.2 Kazakhstan
6 Anti-obesity Drugs Sales Market by Type (2015-2026)
6.1 Global Anti-obesity Drugs Historic Market Size by Type (2015-2020)
6.2 Global Anti-obesity Drugs Forecasted Market Size by Type (2021-2026)
7 Anti-obesity Drugs Consumption Market by Application(2015-2026)
7.1 Global Anti-obesity Drugs Historic Market Size by Application (2015-2020)
7.2 Global Anti-obesity Drugs Forecasted Market Size by Application (2021-2026)
8 Company Profiles and Key Figures in Anti-obesity Drugs Business
8.1 Merck
8.1.1 Merck Company Profile
8.1.2 Merck Anti-obesity Drugs Product Specification
8.1.3 Merck Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Vivus
8.2.1 Vivus Company Profile
8.2.2 Vivus Anti-obesity Drugs Product Specification
8.2.3 Vivus Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Arena Pharmaceuticals
8.3.1 Arena Pharmaceuticals Company Profile
8.3.2 Arena Pharmaceuticals Anti-obesity Drugs Product Specification
8.3.3 Arena Pharmaceuticals Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Novo Nordisk
8.4.1 Novo Nordisk Company Profile
8.4.2 Novo Nordisk Anti-obesity Drugs Product Specification
8.4.3 Novo Nordisk Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Orexigen Therapeutics
8.5.1 Orexigen Therapeutics Company Profile
8.5.2 Orexigen Therapeutics Anti-obesity Drugs Product Specification
8.5.3 Orexigen Therapeutics Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Pfizer
8.6.1 Pfizer Company Profile
8.6.2 Pfizer Anti-obesity Drugs Product Specification
8.6.3 Pfizer Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Alizyme
8.7.1 Alizyme Company Profile
8.7.2 Alizyme Anti-obesity Drugs Product Specification
8.7.3 Alizyme Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Company Profile
8.8.2 GlaxoSmithKline Anti-obesity Drugs Product Specification
8.8.3 GlaxoSmithKline Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Roche
8.9.1 Roche Company Profile
8.9.2 Roche Anti-obesity Drugs Product Specification
8.9.3 Roche Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Amylin
8.10.1 Amylin Company Profile
8.10.2 Amylin Anti-obesity Drugs Product Specification
8.10.3 Amylin Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Boehringer Ingelheim
8.11.1 Boehringer Ingelheim Company Profile
8.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Specification
8.11.3 Boehringer Ingelheim Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Eisai
8.12.1 Eisai Company Profile
8.12.2 Eisai Anti-obesity Drugs Product Specification
8.12.3 Eisai Anti-obesity Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Anti-obesity Drugs (2021-2026)
9.2 Global Forecasted Revenue of Anti-obesity Drugs (2021-2026)
9.3 Global Forecasted Price of Anti-obesity Drugs (2015-2026)
9.4 Global Forecasted Production of Anti-obesity Drugs by Region (2021-2026)
9.4.1 North America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Anti-obesity Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Anti-obesity Drugs by Application (2021-2026)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Anti-obesity Drugs by Country
10.2 East Asia Market Forecasted Consumption of Anti-obesity Drugs by Country
10.3 Europe Market Forecasted Consumption of Anti-obesity Drugs by Countriy
10.4 South Asia Forecasted Consumption of Anti-obesity Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Anti-obesity Drugs by Country
10.6 Middle East Forecasted Consumption of Anti-obesity Drugs by Country
10.7 Africa Forecasted Consumption of Anti-obesity Drugs by Country
10.8 Oceania Forecasted Consumption of Anti-obesity Drugs by Country
10.9 South America Forecasted Consumption of Anti-obesity Drugs by Country
10.10 Rest of the world Forecasted Consumption of Anti-obesity Drugs by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.2 Anti-obesity Drugs Distributors List
11.3 Anti-obesity Drugs Customers
12 Industry Trends and Growth Strategy
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Anti-obesity Drugs Market Growth Strategy
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI